Cite

HARVARD Citation

    Takakuwa, T. et al. (2021). Outcomes of ixazomib/lenalidomide/dexamethasone for multiple myeloma: A multicenter retrospective analysis. European journal of haematology. pp. 555-562. [Online]. 
  
Back to record